Pneumocystis jirovecii pneumonia, also known as PCP, is a life-threatening fungal lung infection caused by the opportunistic organism Pneumocystis jirovecii, primarily affecting individuals with weakened immune systems.
Hyperbaric oxygen therapy could potentially enhance immune response, reduce inflammation, and promote healing in patients with Pneumocystis jirovecii pneumonia, improving overall outcomes.